Ankylosing spondylitis (AS) has been associated with human leukocyte antigen (HLA)-B27 for over 30 years; however, the mechanism of action has remained elusive. Although many studies have reported associations between AS and other genes in the major histocompatibility complex (MHC) in AS, no conclusive results have emerged. To investigate the contribution of non-B27 MHC genes to AS, a large cohort of AS families and controls were B27 typed and genotyped across the region. Interrogation of the data identified a region of 270 kb, lying from 31 952 649 to 32 221 738 base pairs from the p-telomere of chromosome 6 and containing 23 genes, which is likely to include genes involved with susceptibility to AS.
Introduction
Ankylosing spondylitis (AS; Mendelian Inheritance in Man (MIM) 106300) is the prototype of a group of rheumatic diseases called the seronegative spondyloarthropathies (SpAs). It is a common chronic inflammatory disorder characterized by sacroiliitis, ankylosis of the spine and enthesitis. Additional disease features include peripheral joint arthritis, uveitis, cardiovascular disease and, rarely, pulmonary fibrosis.
The association of AS with the major histocompatibility (MHC) class I antigen-presenting molecule human leukocyte antigen (HLA)-B27 (B27) has been recognized for over 30 years. [1] [2] [3] However, although B27 is almost essential for the inheritance of AS within families, there are other genetic risk factors involved.
Susceptibility to AS has been estimated to have additive genetic factors accounting for 490% of the population variance. 4 In twins, it has been estimated that B27 has an attributable risk of 16%. 4 Furthermore, although 95% of Caucasian AS patients are B27-positive, only a small proportion of the 8% of B27-positive individuals in the population go on to develop disease. [5] [6] [7] This indicates that although B27 is almost essential for the inheritance of AS within families, there are other genetic risk factors involved. Recurrence risk ratio modelling in different degrees of relatives suggests that 2-6 genes are likely to interact multiplicatively in determining susceptibility to AS. 8 Four genomewide linkage screens have been performed, showing linkage to genomic areas outwith the MHC, while confirming strong linkage to the region. [9] [10] [11] [12] Many association studies have investigated the non-B27 MHC associations of AS, with little consensus (Figure 1) . 4, The causes of this are likely to be confounding factors such as heterogeneous disease populations, small sample sizes and study designs that do not adequately control for the strong association with B27 and the extensive linkage disequilibrium with that allele that exists across the MHC.
This study was designed to investigate the association of MHC class II and III markers with AS, controlling for the effect of B27. Genotyping was performed in 229 affected sibling pair (ASP) families in order to ensure haplotypic accuracy. Single-nucleotide polymorphisms (SNPs) were designed to cover the 1-Mb region between TNF and DRB1, and, where possible, were located within coding sequences. Additionally, all family members were typed to determine B27 status (homozygous, heterozygous, or non-carrier) and DRB1 subtype (categorized DRB1*01-10). A large population of ethnically matched controls, fully typed for HLA-B and DRB1 subtypes, was utilized to ensure consistency of results and accuracy of allele frequencies. The design of the study ensured full control for B27 by haplotype analysis, and comparison of DRB1 subtypes on the haplotypes. The study indicates that a second disease gene is likely to be located in the MHC class III region; however, complex linkage disequilibrium (LD) patterns confound the exact resolution.
Results

Power and LD
The genetic power of this study was determined using the following parameters: a disease prevalence of 0.1% and an allele frequency of 0.05, adopting a dominant model, with an a value of 0.05. For the within-family study using parent-case trio data from the ASP families (n ¼ 229), the study has 80% power to identify association with a genotype relative risk (GRR) of 2.6. For casecontrol analyses, the number of cases and controls for specific comparisons varied, but the study has 480% power to identify GRRs of 2.0-2.5 for all such analyses. 52 For higher allele frequencies, the power increases, and thus these power estimates are for the smallest significant effect sizes likely to operate. LD in the region was assessed using the founders of the population. Pairwise LD was observed with B27 and DRB1 across the region, and LD between the SNPs was highly variable. The minor allele frequencies (MAF), D 0 values and associated P-values can be found in Table 1 . The allele-specific D 0 values for HLA-DRB1 are as follows: for DRB1*01, 0.47; DRB1*02, 0.52; DRB1*03, 0.9; DRB1*04, 0.064; DRB1*05, 0.42; DRB1*06, 0.37; DRB1*07, 0.84; DRB1*08, 0.33; DRB1*09, 0.27 and DRB1*10, 1 (all Po10
À6
).
Within-family association
The conditional extended transmission disequilibrium test (CETDT 53 ) was utilized to determine association with susceptibility to AS. Initial analysis was carried out without controlling for the effects of B27. This showed a strong association with
) and SNP 10 (P corrected ¼ 6.6 Â 10
À3
). Forward selection was used to remove the markers with the strongest effect. Thus, controlling for B27, two SNPs showed significant association with susceptibility to AS (SNP 10,
) and a dominance effect was also observed with SNPs 3 and 11 ( Table 2) .
To help determine which of these markers was primarily associated with AS, we initially controlled for B27 in combination with SNP 10, then SNP 16, then both SNP 10 and SNP 16 ( Table 3 ). In these analyses, when controlling for B27 and SNP 10, SNP 16 remained significant (P ¼ 1.4 Â 10
À2
) and DRB1 showed a significant GRR (P ¼ 1.9 Â 10
). When controlling for B27 and SNP 16, SNP 10 remained significant (P ¼ 3.1 Â 10 À3 ). 
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Finally, on controlling for B27, SNP10 and SNP16, DRB1 again showed a significant GRR (P ¼ 4.7 Â 10
À2
). Quantitative transmission disequilibrium test (QTDT 54 ) analysis showed that although the heritability of age of onset was high (additive genetic effect 50%;
), no significant association or linkage was observed between MHC markers and the age of onset.
Case-control analysis
Tests for association with disease susceptibility were carried out for subtypes of DRB1 between B27 antigenpositive, matched cases (one per family; n ¼ 206) and controls (n ¼ 1462). Only individuals with full genotype information at both loci were included in the analysis. This study had X80% power to detect an effect of GRR 2.0 at Pp0.05. Globally, DRB1 had a strong association with disease (P ¼ 2.9 Â 10 À6 ), with the allelic relative predispositional effect (RPE) test showing the underrepresentation of DRB1*03 contributing to the association (Table 4) . Case-control analysis was then performed using the B27/DRB1 haplotype data. This consisted of 211 B27-positive case chromosomal strands compared with 1541 B27-positive control strands, and 206 B27-negative case strands compared with 40 611 B27-negative control strands. Global association of DRB1 with susceptibility to AS was found to be present, irrespective of whether the haplotype carried B27 (B27-positive strand, P ¼ 4 Â 10
À4
; B27-negative strand, P ¼ 5 Â 10 À8 ). RPE analysis of DRB1 alleles on the B27-positive strands showed that DRB1*07 and DRB1*06 overrepresented in cases, compared with B27-positive controls (odds ratio (OR) ¼ 2.97 and 2.05; P ¼ 1.7 Â 10 À3 and 3.6 Â 10 À3 , respectively). The RPE analysis for the B27-negative strands showed the DRB1*03 allele to be underrepresented in cases (OR ¼ 0.32, P ¼ 4.2 Â 10
À6
) and the DRB1*01 allele to be overrepresented (OR ¼
À3
). The results are summarized in Table 4 .
Comparison of proband haplotypes
Disease-associated haplotypes of B27/DRB1 that had a significant effect on susceptibility to AS in the case-control analysis (B27 þ /DRB1*07 þ and B27À/ DRB1*03 þ ) were analyzed by comparison of proband haplotypes. Each set of disease-associated haplotypes was compared to its counterpart of disease-unassociated haplotypes. Therefore, B27 þ /DRB1*07 þ were compared with B27 þ /DRB1*07À haplotypes (n ¼ 211 haplotypes) and B27À/DRB1*03 þ were compared with B27À/ DRB1*03À haplotypes (n ¼ 206 haplotypes). Haplotype information available for each strand analyzed was [B27 status/19 SNPs/DRB1 subtype]. Therefore, each analysis controlled for the B27 and DRB1 status of the chromosomes, allowing a direct comparison of the intervening 19 SNPs. Comparisons were performed between proband haplotypes only (one case from each family; n ¼ 229). In each comparison, three-marker SNP minihaplotypes were compared between chromosomes, either associated with disease or not, using standard w Non-B27 MHC associations of ankylosing spondylitis A-M Sims et al methods. The Àlog 10 P-value was plotted for each threemarker mini-haplotype against chromosomal position ( Figure 2 ). The disease-associated SNP haplotypes differ significantly from SNP haplotypes not associated with disease in the region bound by SNPs 7 and 17 (B270 kb, 31 952 649-32 221 738 base pairs from the p-telomere of chromosome 6) and an overlapping region bound by SNPs 10 and 14 (B86 kb; Figure 2 ). The broad region contains 23 known genes and the narrow region encompasses eight of these. Both regions incorporate a documented hypervariable region, the RCCX region. 55 
Discussion
This study was designed to determine the MHC component of AS, while controlling for the known B27 associations. Twenty-one markers, including B27, DRB1 and 19 SNPs, were typed in 229 British Caucasian ASP families in order to allow confident haplotype construction. A large ethnically matched population of HLA-typed hematopoietic stem cell donors was used as a control cohort.
The data presented here provide evidence suggesting that genes other than B27, located in the MHC class II and III regions, are involved in susceptibility to AS.
Considering associations with age of onset, we saw strong substantial heritability, but no evidence of MHC allelic association or linkage. We have previously demonstrated weak heritability (h 2 ¼ 0.22) and nominal linkage to chromosome 6p with age of symptom onset in an overlapping data set. 56 Compared with B27-negative cases, B27 carriers have previously been demonstrated to have onset of symptoms at an earlier age. 27, 57, 58 In the current study, there were no B27-negative cases, perhaps explaining the lack of association seen.
Many studies have reported HLA-DRB1 associations with AS susceptibility (Figure 1 ). However, it has proven difficult to replicate associations of individual DRB1 alleles in different populations, possibly because it may not be DRB1 itself that affects disease status, but rather other genes on these disease-associated haplotype. The MHC has complex LD patterns that can vary in different populations, hence possibly highlighting different alleles in different studies.
In the current study, strong DRB1 association was observed regardless of the B27 status of the chromosome, indicating the presence of a further disease gene in the area. Case-control analysis matching for B27 identified two haplotypes (B27 þ /DRB1*07 þ and B27À/ DRB1*03 þ ; Table 4 ) that are associated with susceptibility to disease. Single-marker TDT disease susceptibility analysis showed a strong B27 association (P ¼ 2.8 Â 10
À13
), as well as association with DRB1 (P ¼ 1.6 Â 10
À3
) and several of the intervening SNPs. However, such analyses cannot differentiate between true associated markers and those in LD with B27. Therefore, conditional analysis was performed, to control for the effect of B27 (Tables 2 and 3 ). This showed two markers independently associated with disease, SNPs 10 and 16. Further conditional analysis for B27 in combination with SNPs 10 and 16 suggests that they are associated with disease independently of each other, and B27. SNPs 3 and 11 show a significant dominance effect independent of B27 ( Table 2) . SNPs 10 and 16 are in strong LD with each other (and other markers), and the low minor allele frequencies means that the haplotype pair is at a low frequency in the population (MAF ¼ 0.03, D 0 ¼ 1.0 and P ¼ 0.27; Table 1 ), and therefore, has low population attributable risk. This suggests that the SNPs Non-B27 MHC associations of ankylosing spondylitis A-M Sims et al are likely to be in LD with more common variants in the true disease-modifying gene.
In the CETDT studies with susceptibility to disease, DRB1 showed association only once the major effects of B27, SNP 10 and SNP 16 were controlled for (Table 3) . This supports the hypothesis that in the case of disease susceptibility, the DRB1 associations are haplotypic, and the true disease-modifying gene lies elsewhere in the region.
In the case-control study, comparing disease-associated MHC class III SNP haplotypes with haplotypes not associated with disease reveals an area of divergence (Figure 2) . The B270 kb in the class III region is of interest, as it is likely to harbor a gene(s) that is truly involved in disease pathogenesis. This region contains 23 known genes, including eight in the overlap region. These include C4A/B, CREBL1, CYP21A2 and TNXB. The region of interest also includes the known hypervariable region, RCCX. All the genes within the overlap region are plausible candidates for involvement in the pathogenesis of AS. C4A/B are components of the complement pathway involved in inflammatory and immune responses. Complotypes of the C4A/B locus have previously been associated with AS, but the finding was restricted to B27-negative cases.
27 CREBL1 is involved in the unfolded protein stress response in the endoplasmic reticulum. CYP21A2 is a member of the cytochrome P450 family, of which the AS-associated gene CYP2D6 is also a member. 59, 60 TNXB encodes a member of the tenascin family of extracellular matrix proteins, mutations of which are involved in some forms of the benign joint hypermobility disorder, Ehlers-Danlos syndrome. 61 RCCX contains four genes, pseudogenes or gene fragments (CYP21A1P, TNXA, STK19P and C4A). Four major structures of this region are present in the Caucasian populations. These vary in a modular manner, with different pseudogenes or gene fragments present on different haplotypes. The modules are a major cause of mutations from pseudogenes or gene segments in the RCCX region to their corresponding functional genes, where recombination events can allow within-gene mutations, gene conversions, deletions and duplications. 55 In summary, this study strongly suggests that the MHC class III region harbors a disease-modifying gene for AS. The power of the study is not sufficient to pinpoint the disease-associated gene(s) precisely, but nonetheless our data are suggestive that a major ASassociated gene lies in a 270 kb segment of the MHC class III region. DRB1 was associated with disease susceptibility, likely independent of B27; however, these associations are likely to be attributable to LD with a true disease-causing variant. Identification of the true disease-associated genes in this region will require investigation of substantially larger data sets with greater marker densities, and may be assisted by studies of different ethnic backgrounds with different MHC haplotypic organization.
Materials and methods
Patient recruitment and control subjects Two hundred and twenty-nine ASP families with AS were recruited through patients attending the Nuffield Orthopaedic Centre (Oxford, UK) ; the Royal National Hospital for Rheumatic Disease (Bath, UK) AS Database; in response to public appeals; and by referral from British rheumatologists, all with relevant ethical approval (MREC project number 98/5/23). All patients were seen by a qualified rheumatologist to confirm AS, as defined by the modified New York criteria. 62 The age of disease onset was determined at this stage. All affected individuals were B27 positive. Data on over 30 000 British Caucasian healthy control subjects (bone marrow donors recruited by Dr Chris Darke, Welsh Blood Service, Pontyclun, UK) was used for comparison. They had no history of arthritis and had been fully subtyped for HLA class I and II.
Genotyping B27 homozygosity/heterozygosity status was determined by amplification refractory mutation system polymerase chain reaction, as detailed in Table 5 . Eight PCRs were performed per sample. PCRs 1-3 encompass the most common B27 subtypes. PCRs 4-8 cover the remaining common HLA-B alleles. DRB1 subtyping was performed to the resolution of the classical DRB1*01-10 alleles using the SNaPshot method. 63 Nineteen SNPs were identified within the 1-Mb region between TNF and DRB1, with an average inter-marker distance of 35 kb. Genotyping was carried out by matrixassociated laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry 64 or restriction fragment length polymorphism. Table 6 details the SNPs with their position, genotyping method and associated primers. All genotyping passed stringent quality control tests. Hardy-Weinberg equilibrium, Mendelian inconsistencies and excess recombination events were detected using PEDSTATS 65 and MERLIN. 66 
Statistical analyses
Haplotype construction in control data was performed using PHASE. 67 From data on 31 480 control individuals (62 960 input alleles), 42 152 phase-known (490% posterior probability) HLA-B/HLA-DRB1 control haplotypes (from 21 076 individuals; 67% of the total) were ascertained and used in the following analyses, of which 1541 haplotypes (B4%) were B27-positive. After haplotypes were ascertained, the HLA-B and HLA-DRB1 loci were recoded to match that of the family data (B27 homozygous/heterozygous and DRB1*01-10). Allele frequencies of DRB1 subtypes were compared by w 2 test between the B27-positive control haplotypes (n ¼ 1541) and the B27 homozygotes haplotypes in the families (n ¼ 158). These allele frequencies were not significantly different (data not shown), giving confidence to the haplotypes produced by PHASE.
Within-family testing for association was performed using CETDT 53 for susceptibility to disease. Because of skewing of age-of-onset data and some extreme outliers (42 s.d. from mean of age-of-onset distribution), cases with disease onset reported as 450 years of age were excluded and the data log-transformed. Following this, the data were no longer skewed (skewness 0, standard error 0.1) or kurtotic (kurtosis 0.3, standard error 0.2), consistent with a normal distribution. The total association model of QTDT 54 was employed to determine association with the transformed age-of-disease onset data. QTDT was performed for all single markers and B27/DRB1 haplotypes in the ASP families. P-values were corrected for multiple testing using the Nyholt 68 method. In this instance, the effective number of independent marker loci is 18.4, giving the level of significance for these analyses at 2.7 Â 10
À3
. Case-control analysis compared the B27 and DRB1 allele frequencies between probands (one from each family, n ¼ 229) and controls (n ¼ 21 076). Haplotypic case-control analysis was performed for B27/DRB1 using the same groups (haplotype numbers; probands n ¼ 458; controls n ¼ 42 152). Both sets of analyses were carried out using standard w 2 methods. In each analysis, the RPE of each DRB1 subtype was determined by forward selection and removal of the main allelic effect.
Significant B27/DRB1 haplotypes identified from case-control analysis were extended in the proband to include the 19 intervening SNPs (GENEHUNTER 69 ). The haplotype of interest was then cross-tabulated with its opposing haplotype using SPSS, and significance was assessed using standard w 2 methods. Pairwise LD (D 0 ) between markers was calculated in the founders of the ASP families using haploXT. 70 Allelespecific LD (D 0 ) between B27 and HLA-DRB1 was calculated using the program 2BY2. 71 
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